Ndeye Méry Dia Badiane

Suggest Changes
Learn More
BACKGROUND The efficacy of various antiretroviral (ARV) therapy regimens for human immunodeficiency virus type 2 (HIV-2) infection remains unclear. HIV-2 is intrinsically resistant to the(More)
  • 1